Alliances between pharmaceutical companies can take a number of forms to accommodate the strategic interests of the partnering firms. These alliances also occur at different stages in the product lifecycle, from early stage product development, to late stage development to the sales and marketing of an approved product, and even occur once a product is approaching or reaches patent expiry. CRA’s Life Sciences Practice has been asked to assess the value of different types of marketing alliances.
The Convergence of Financial and Societal Value, and What It Means
In this Marakon Commentary, Charlie Johnson and Christine Delivanis discuss how until very recently, the market and society more generally were less aware of...